The Cure and The Disease (part 2)

Date: Wednesday, June 24, 2020
Virtual Event

About The Event

Event Detail

The Cure and The Disease (part 2)

The Cure and the Disease (part 2) is the theme of this Executive Briefing in our “Analyzing Pandemics” series. Attendees will gain context and perspective regarding the biochemistry of the coronavirus and expert insights on vaccine and therapeutic solutions to fight COVID-19.

 

Detailed webinar instructions and materials available upon registration. COVID-19 pandemic resources available below.

 

Click here for the video replay.

 


Rest assured we do not sell your email address or other registration information. 

The GIC’s mission is to provide a forum for a thoughtful, unbiased global dialogue on emerging issues that impact the economy, policy and geopolitics. During these challenging time related to the COVID-19 pandemic, we think it is important to share our content as a public service. 

As a reminder, the Global Interdependence Center is a 501(c)(3) nonprofit organization. We rely on voluntary contributions to bring our high quality content to the public. If you enjoy and find our programming valuable, we encourage you to make a tax deductible donation of $25, $50, or $100 to GIC in support of future webinars and live conferences, or consider joining as a GIC Member.


Resources on COVID-19:

Event Location

Date: Wednesday, June 24, 2020 Time: 4:00 PM - 5:00 PM

Location: Virtual Event

Download iCal

Speakers

Theresa Madaline, M.D.

Theresa Madaline, M.D.

Healthcare Epidemiologist, Montefiore Health System

Dr. Madaline earned her medical degree from Thomas Jefferson University in 2008. She completed her Internal Medicine residency training at Mount Sinai in 2011 and graduated from the Einstein/Montefiore Infectious Diseases (ID) Fellowship program in 2013.  

Read More

Barry Zingman, M.D.

Barry Zingman, M.D.

Clinical Director of Infectious Diseases at the Moses Division, Montefiore Health System

Dr. Barry Zingman is Clinical Director of Infectious Diseases at the Moses Division of Montefiore Medical Center; Medical Director of the Montefiore AIDS Center; Professor of Medicine at Einstein; and Principal Investigator at Montefiore/Einstein of the NIH Adaptive COVID-19 Treatment Trial (ACTT) of remdesivir and other therapies for people hospitalized with severe COVID-19 infection.

Read More

Andrew D. Racine, M.D., Ph.D.

Andrew D. Racine, M.D., Ph.D.

System Senior Vice-President and Chief Medical Officer of the Montefiore Health System and Executive Director of the Montefiore Medical Group

Andrew D. Racine, M.D., Ph.D. is the System Senior Vice-President and Chief Medical Officer of the Montefiore Health System and Executive Director of the Montefiore Medical Group.  He holds appointments as Professor of Pediatrics at the Albert Einstein College of Medicine (AECOM) and Research Associate at the National Bureau of Economic Research (NBER) in Manhattan. 

Read More